(S)-N-(p-chlorophenylsulfonyl)proline | 73096-27-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-N-(p-chlorophenylsulfonyl)proline
• 英文别名: N-(4-chlorophenylsulfonyl)-(S)-proline；N-4-chlorobenzenesulfonyl-L-proline；L-Proline, 1-[(4-chlorophenyl)sulfonyl]-；(2S)-1-(4-chlorophenyl)sulfonylpyrrolidine-2-carboxylic acid
• CAS: 73096-27-2
• 化学式: C₁₁H₁₂ClNO₄S
• mdl: MFCD08690645
• 分子量: 289.74
• InChiKey: JXMXHRZHMZMBDK-JTQLQIEISA-N

物化性质

• 熔点：
  102-105°C
• 沸点：
  483.7±55.0 °C(Predicted)
• 密度：
  1.515±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  83.1
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2935009090

反应信息

• 作为反应物：
  描述：

  (S)-N-(p-chlorophenylsulfonyl)proline 在 氯化亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 1.0h， 生成 (S)-9-{N-(p-chlorophenylsulfonyl)prolinyl}-β-carboline
  参考文献：
  名称：

  Preparation of both enantiomers of 1-allyl-1,2,3,4-tetrahydro-β-carboline using allyltin reagents and a chiral auxiliary derived from l-proline

  摘要：

  beta -Carboline, which had an acyl group derived from L-proline at the 9-position, reacted with allyltributyltin and 2,2,2-trichloroethyl chloroformate, to afford an 1-allyl-1,2-dihydro-beta -carboline derivative in a diastereo selective manner. The chiral acyl group at N-9 was readily eliminated by aqueous alkali to give a corresponding carboxylic acid. The formed 1-allyl-1,2-dihydro-beta -carboline was transformed via two reduction steps to 1-alkyl-1,2,3,4-tetrahydro-beta -carboline in high ee. When the allylation was carried out using tetraallyltin instead of allyltributyltin, the stereoselectivity was reversed, and the antipode of the allyl adduct was obtained in high yield and ee in the presence of tin(IV) tetraiodide. Thus, it was found that both enantiomers of 1-allyl-beta -carboline were obtained in good enantioselectivities by the use of the same chiral auxiliary. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(01)00684-6
• 作为产物：
  描述：

  (S)-1-(4-Chloro-benzenesulfonyl)-pyrrolidine-2-carbonyl chloride 在 sodium hydroxide 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 24.5h， 生成 (S)-N-(p-chlorophenylsulfonyl)proline
  参考文献：
  名称：

  Preparation of both enantiomers of 1-allyl-1,2,3,4-tetrahydro-β-carboline using allyltin reagents and a chiral auxiliary derived from l-proline

  摘要：

  beta -Carboline, which had an acyl group derived from L-proline at the 9-position, reacted with allyltributyltin and 2,2,2-trichloroethyl chloroformate, to afford an 1-allyl-1,2-dihydro-beta -carboline derivative in a diastereo selective manner. The chiral acyl group at N-9 was readily eliminated by aqueous alkali to give a corresponding carboxylic acid. The formed 1-allyl-1,2-dihydro-beta -carboline was transformed via two reduction steps to 1-alkyl-1,2,3,4-tetrahydro-beta -carboline in high ee. When the allylation was carried out using tetraallyltin instead of allyltributyltin, the stereoselectivity was reversed, and the antipode of the allyl adduct was obtained in high yield and ee in the presence of tin(IV) tetraiodide. Thus, it was found that both enantiomers of 1-allyl-beta -carboline were obtained in good enantioselectivities by the use of the same chiral auxiliary. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(01)00684-6

文献信息

• [EN] HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1<br/>[FR] AMIDES HÉTÉROCYCLIQUES EN TANT QUE MODULATEURS DE LA TRPA1
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2010141805A1

  公开（公告）日：2010-12-09

  Certain heterocyclic amide compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPA1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease.

  描述了某些杂环酰胺化合物。这些化合物可用于制备药物组合物，以及用于治疗由TRPA1活性介导的疾病状态、紊乱和条件，如疼痛、关节炎、瘙痒、咳嗽、哮喘或炎症性肠病的方法。
• HETEROCYCLIC AMIDE DERIVATIVE AND MEDICINE CONTAINING SAME
  申请人：AJINOMOTO CO., INC.

  公开号：US20150284375A1

  公开（公告）日：2015-10-08

  Compound represented by formula (I): wherein each symbol is as defined herein, exhibit TRPA1 antagonist activity, and are useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.

  由式(I)表示的化合物：其中每个符号如本文所定义，具有TRPA1拮抗活性，并且对涉及TRPA1拮抗和TRPA1的疾病的预防或治疗是有用的。
• Pentacoordinated chlorosilanes with C,O-chelate ligands derived from N-methyl-N'-organosulfonyl-prolinamides*
  作者：A. A. Nikolin、D. E. Arkhipov、A. G. Shipov、E. P. Kramarova、N. A. Koval˙ˈchuk、A. A. Korlyukov、V. V. Negrebetsky、Yu. I. Baukov、A. R. Bassindale、P. G. Taylor、A. Bowden、S. Yu. Bylikin

  DOI：10.1007/s10593-012-0949-7

  日期：2012.3

  silyloxonium chlorides [RSO2-ProN(Me)CH2SiMe2OH2]Cl or disiloxanes [RSO2-Pro-N(Me)CH2SiMe2]2O. X-ray diffraction structural analysis showed that the silicon atom in the chlorides and silyloxonium chlorides is pentacoordinated due to an intramolecular O → Si bond and has distorted trigonal-bipyrimidal configuration. 29Si NMR spectroscopy showed that the disiloxanes and bicyclic sila-5-piperazinone have a tetracoordinated

  酰胺RSO 2 -Pro-NHMe与ClCH 2 SiMe 2 Cl在（Me 3 Si）2 NH存在下的反应生成了带有有机磺酰基基团的五配位氯硅烷RSO 2 -Pro-N（Me）CH 2 SiMe 2 Cl（R = Me中的pH值，4-CLC 6 ħ 4，4- BRC 6 ħ 4，4-MEC 6 ħ 4，和4-O 2 NC 6 H ^ 4）附着在脯氨酸的氮原子上 制备这些化合物的另一种方法包括在第一步骤中通过二甲基氯甲基氯硅烷使脯氨酸甲酰胺的环甲硅烷基甲基化，得到先前未报道的杂环2-sila-5-哌嗪酮系统。合成的双环硅环烷是与脯氨酸残基缩合的2-sila5-哌嗪酮。磺酰氯RSO 2 Cl的作用导致硅烷基环Si-N键断裂，从而得到所需的氯硅烷。这些产物的水解，取决于反应条件，给出氯化硅氧鎓氯化物[RSO 2 -ProN（Me）CH 2 SiMe 2 OH 2 ] Cl或二硅氧烷[RSO 2
• In Vitro Aldose Reductase Inhibitory Activity of Substituted N-Benzenesulfonylglycine Derivatives
  作者：Jack DeRuiter、Abram N. Brubaker、Martha A. Garner、Jeffrey M. Barksdale、Charles A. Mayfield

  DOI：10.1002/jps.2600760213

  日期：1987.2

  A number of N-benzenesulfonylglycines, alanines, sarcosine, and prolines, which contain the minimum pharmacophore moieties necessary for aldose reductase inhibitory activity, were prepared and tested in the rat lens assay. In this assay, the benzenesulfonylglycines are considerably more potent than the corresponding alanine and sarcosine derivatives which, in turn, are more active than the proline

  制备了许多N-苯磺酰基甘氨酸，丙氨酸，肌氨酸和脯氨酸，它们含有醛糖还原酶抑制活性所必需的最小药效团部分，并在大鼠晶状体测定中进行了测试。在该测定中，苯磺酰基甘氨酸比相应的丙氨酸和肌氨酸衍生物的效力明显更高，而丙氨酸和肌氨酸衍生物的活性又高于脯氨酸类似物。在单取代的苯磺酰基甘氨酸中，2-硝基和4-氨基衍生物的活性最高，其50％抑制浓度（IC50）值分别为13和16 microM。评价的最有效的衍生物是β-和α-萘磺酰基甘氨酸，IC50值分别为0.4和1.3 microM。
• PROLINE SULFONAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
  申请人：Boss Christoph

  公开号：US20130150424A1

  公开（公告）日：2013-06-13

  The present invention relates to (S)-proline sulfonamide compounds of formula (I) wherein R 1 and R 2 are as described in the description, or pharmaceutically acceptable salts thereof, for use in the prevention or treatment of diseases or disorders related to the orexin system. The present invention also relates to the use of (S)-proline sulfonamide compounds of formula (II) as pharmaceuticals, to pharmaceutical compositions comprising compounds of formula (II), and especially their use in the prevention or treatment of diseases or disorders related to the orexin system.

  本发明涉及公式（I）中的（S）-脯氨酸磺酰胺化合物，其中R1和R2如说明书中所述，或其药学上可接受的盐，用于预防或治疗与促进素系统相关的疾病或障碍。本发明还涉及使用公式（II）中的（S）-脯氨酸磺酰胺化合物作为药物，制备含有公式（II）化合物的药物组合物，特别是它们在预防或治疗与促进素系统相关的疾病或障碍方面的使用。